KIDRON MIRIAM

PrivateCIK: 1409232
Location

JERUSALEM, L3

KIDRON MIRIAM (Chief Scientific Officer) received a stock award from ORAMED PHARMACEUTICALS INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 2 awards
InsiderKIDRON MIRIAMCIK 1409232
→
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
-75.58K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
8
Total transactions
417.42K acquired · 493K disposed
Non-Derivative Transactions2

Common Stock

Direct
A · Award

Shares

+208.13K

Price / share

—

Trade value

—

% of position

18.4%
9/24/2026
1.13M→1.34M

Common Stock

Direct
A · Award

Shares

+209.29K

Price / share

—

Trade value

—

% of position

15.6%
9/24/2026
1.34M→1.55M
Total

Net shares

+417.42K

Net value

$0.00

Derivative Transactions6

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

104K shares

Shares

−104K

Strike price

3.16

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

100K shares

Shares

−100K

Strike price

4.80

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

70K shares

Shares

−70K

Strike price

7.77

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

47K shares

Shares

−47K

Strike price

8.14

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

100K shares

Shares

−100K

Strike price

10.40

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

72K shares

Shares

−72K

Strike price

13.89

Held after

0.00

Exercisable

—

9/24/2026
KIDRON MIRIAM — Insider Transaction (Form 4) Filed Sep 25, 2026 | Finecho